Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.34 +0.19 (+0.12%)
Official Closing Price Updated: 7:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration  
Via Benzinga
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
Benzinga 
Via Benzinga
Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say
Discover how Goldman Sachs analysts analyze S&P 500 ROE in light of rising interest rates and the AI revolution. Consider these stock picks. 
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
(JNJ) - Analyzing Johnson & Johnson's Short Interest
Via Benzinga
Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine
Sanofi SA (NASDAQ: SNY) struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ), to develop and commercialize the vaccine candidate for extraintestinal&nb 
Via Benzinga
Johnson & Johnson Urged To Expand Access Tuberculosis Medication
Global health aid agency Unitaid is advocating for expanded access to tuberculosis (TB) drug, bedaquiline, produced by Johnson & Johnson (NYSE: JNJ). 
Via Benzinga
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Kenvue says rewarding shareholders is an important part of its strategy. 
Via The Motley Fool
Is Kenvue Stock Too Pricey to Buy?
Its valuation depends on its brands being highly valuable indefinitely. 
Via The Motley Fool
3 Magnificent Dividend Stocks to Buy in October
These stocks come with great dividends and more. 
Via The Motley Fool
Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times
Are you looking to invest in recession-proof stocks? Here are three stocks that thrive in tough economic times. 
Via InvestorPlace
Johnson & Johnson Unusual Options Activity
Via Benzinga
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
Dividend stocks have proven themselves over time to outperform non-paying stocks so it's smart to buy them when they go on sale. 
Via InvestorPlace
These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders
Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs
AstraZeneca Plc (NASDAQ: AZN), Bristol Myers Squibb & Co (NYSE: BMY), and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiation 
Via Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an  
Via Benzinga
Why Immunovant Stock Is Bolting Higher Today
The company may have best-in-class autoimmune disease therapy under its roof. 
Via The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria.  More than a million people worldwide succumb to infections caused... 
Via Benzinga
3 Things About Johnson & Johnson That Smart Investors Know
J&J shares have missed out on the market rally so far this year. 
Via The Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
Recent bumps in the road won't deter these companies. 
Via The Motley Fool
3 Blue Chip Safe Havens to Shield Your Portfolio
As the market experiences heightened volatility and uncertainty, it's worth exploring defensive stocks like JNJ, PG, and VZ for stability amid the uncertainty. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
3 Reasons SharkNinja Is Swimming Toward New Highs
Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders. 
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
High-quality dividend stocks are rarely cheap. These two names are an exception. 
Via The Motley Fool
Flee to Healthcare Stocks if Recession Rears its Head?
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Market crashes are inevitable, but certain stocks could limit potential damage. 
Via The Motley Fool
3 No-Brainer Stocks to Buy With $500 Right Now
A modest amount of money can go a long way when it's invested in industry-leading businesses. 
Via The Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape. 
Via InvestorPlace
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
Exposures Economy Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
82 83 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.